KIAA0101 and UbcH10 knockdown reduced the proliferation of NSCLC cells in vitro and suppressed tumor growth in vivo, suggesting that UbcH10 and KIAA0101 are potential therapeutic targets for the treatment of NSCLC by ameliorating SAC function. This evidence concerns the gene PCLAF and non-small cell lung carcinoma.